GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » 12-1 Month Momentum %

Blau Farmaceutica (BSP:BLAU3) 12-1 Month Momentum % : -37.14% (As of Apr. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-28), Blau Farmaceutica's 12-1 Month Momentum % is -37.14%.

The industry rank for Blau Farmaceutica's 12-1 Month Momentum % or its related term are showing as below:

BSP:BLAU3's 12-1 Month Momentum % is ranked worse than
80.85% of 1112 companies
in the Drug Manufacturers industry
Industry Median: -5.73 vs BSP:BLAU3: -37.14

Competitive Comparison of Blau Farmaceutica's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blau Farmaceutica's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Blau Farmaceutica's 12-1 Month Momentum % falls into.



Blau Farmaceutica  (BSP:BLAU3) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blau Farmaceutica  (BSP:BLAU3) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Blau Farmaceutica 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Blau Farmaceutica (BSP:BLAU3) Business Description

Traded in Other Exchanges
N/A
Address
Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica (BSP:BLAU3) Headlines

No Headlines